JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263085

Human ANGPTL6 knockout A549 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

ANGPTL6 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 4 bp deletion in exon3 and 5 bp deletion in exon3.

View Alternative Names

AGF, ANGL6_HUMAN, Angiopoietin like 6, Angiopoietin-like protein 6, Angiopoietin-related growth factor, Angiopoietin-related protein 5, Angiopoietin-related protein 6

2 Images
Sanger Sequencing - Human ANGPTL6 knockout A549 cell lysate (AB263085)
  • Sanger seq

Unknown

Sanger Sequencing - Human ANGPTL6 knockout A549 cell lysate (AB263085)

Allele-2 : 4 bp deletion in exon3

Sanger Sequencing - Human ANGPTL6 knockout A549 cell lysate (AB263085)
  • Sanger seq

Unknown

Sanger Sequencing - Human ANGPTL6 knockout A549 cell lysate (AB263085)

Allele-1 : 5 bp deletion in exon3

Key facts

Cell type

A549

Species or organism

Human

Tissue

Lung

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 4 bp deletion in exon3 and 5 bp deletion in exon3.

Disease

Carcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263085-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human ANGPTL6 knockout A549 cell lysate", "number":"AB263085-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type A549 cell lysate", "number":"AB263085-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
ANGPTL6
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ANGPTL6 also known as Angiopoietin-like 6 is a protein involved in modulating several physiological processes. The protein has a molecular weight of approximately 54 kDa. ANGPTL6 is expressed in various tissues such as the liver heart and adipose tissue indicating its involvement in systemic functions. The protein is a secretory glycoprotein influencing various cellular mechanisms due to its diverse localization.
Biological function summary

ANGPTL6 functions in the regulation of metabolic processes including glucose and lipid metabolism. It is not part of a larger complex but acts individually in its biological roles. ANGPTL6 has been shown to improve insulin sensitivity and promote energy expenditure. Through these mechanisms it plays an essential role in maintaining metabolic homeostasis and supports cellular health.

Pathways

ANGPTL6 significantly interacts within metabolic and cardiovascular pathways. The protein influences the insulin signaling pathway and is connected to proteins like AKT and PI3K integral components of metabolic regulation. ANGPTL6 also affects pathways involved in angiogenesis providing cross-talk with vascular endothelial growth factor (VEGF)-mediated signaling an important aspect of cardiovascular health.

ANGPTL6 has connections to metabolic syndrome and obesity-related conditions. Its role in maintaining insulin sensitivity and influencing glucose metabolism links it to type 2 diabetes. By modulating pathways related to lipid balance ANGPTL6 also relates to cardiovascular diseases. Associations with proteins such as VEGF and AKT elucidate its involvement in vascular health and metabolic disorders.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com